Clenbuterol and anabolic steroids: A previously unreported cause of myocardial infarction with normal coronary arteriograms

Southern Medical Journal

Volumn 91, Issue 8, 1998, Pages 780-784

  Goldstein, Daniel R ^a,b   Dobbs, Thomas ^a,b   Krull, Barbara ^a,b   Plumb, Vance J ^a,b  

^a University of Alabama ^*

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANABOLIC AGENT; CLENBUTEROL; CREATINE KINASE; CREATINE KINASE MB; GLYCERYL TRINITRATE; HEART ENZYME; LIPID; METANDIENONE; STANOZOLOL; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY SPASM; DRUG POTENTIATION; ELECTROCARDIOGRAPHY; FIBRINOLYSIS; HEART INFARCTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION;

EID: 0031858560     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199808000-00019     Document Type: Article

References (20)

1. DuRant RHO, Rickert VI, Asworth US, et al: Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993; 328:922-926
2. Luke JO, Farb A, Virmani R, et al: Sudden cardiac death during exercise in a weight lifter using anabolic steroids: pathological and toxicological findings. J Forens Sci 1990; 35:1441-1447
3. Niemine MS, Ram MY, Viitasalo M, et al: Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996; 17:1576-1583
4. Laroche GP: Steroid anabolic drugs and arterial complications in an athlete-a case history. Angiology 1990; 41:964-969
5. McNutt RA, Ferenchick S, Kirklin PA, et al: Acute myocardial infarction in a 22-year-old world class athlete using anabolic steroids. Am J Cardiol 1988; 62:164
6. Capezzuto A, Achilli A, Suran N: Myocardial infarction in a 21 year old body builder. Am J Cardiol 1989; 63:1530
7. Bowman SJ, Tanna S, Fernando S, et al: Anabolic steroids and infarction. BMJ 1989; 299:632
8. Ferenchick GS, Adelman S: Myocardial infarction associated with anabolic steroid use in a previously healthy 37 year old weight lifter. Am Heart J 1992; 124:507-508
9. Kennedy C: Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 1993; 63:174-176
10. Huie MJ: An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sports Exerc 1994; 26:408-413
11. Fisher M, Appleby M, Rittoo D, et al: Myocardial infarction with extensive inracoronary thrombus induced by anabolic steroids. Br J Clin Pract 1996; 50:222-223
12. Glazer G: Atherogenic effects of anabolic steroids on serum lipid levels. Arch Intern Med 1991; 151:1925-1933
13. Ferenchick GS, Hirokawa S, Mammen EF, et al: Anabohc-androgenic steroid abuse in weight lifters. Am J Hematol 1995; 49:282-288
14. Ferenchick G, Schwartz D, Ball M, et al: Androgenic-anabolic abuse and platelet aggregation: a pilot study in weight lifters. Am J Med Sci 1992; 303:78-82
15. Green DJ, Cable NT, Ranklin JM, et al: Anabolic steroids and vascular responses. Lancet 1993; 342:863
16. De Picoli B, Giada F, Benettin A, et al: Anabolic steroid use in body builders: an echocardiographic study of left ventricular morphology and function. Int J Sports Med 1991; 12:408-412
17. Martinez-Navarro JF: Food poisoning related to consumption of illicit of beta agonists in liver. Lancet 1990; 336:1311
18. Maistro S, Chiesa E, Angeletti R, et al: Beta blockers to prevent clenbuterol poisoning. Lancet 1995; 346:180
19. Pasotti C, Gandolfi P, Capra A, et al: Cardiovascular effects of clenbuterol in comparison with salbutamol in subjects with coronary artery disease. Curr Ther Res 1984; 36:126-132
20. Petro M, Wynne DG, Boheler KR, et al: Clenbuterol induced hypertrophy of latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 1995; 92:483-488